Table 1.
Clinical Measure | WHO 1998 | EGIR 1999 | ATP III 2001 | IDF 2005 | AHA/NHLBI 2005 |
---|---|---|---|---|---|
Criteria | Insulin Resistance + any other 2 | Insulin Resistance + any other 2 | Any other 3 of 5 | Increased WC (population specific) + any other 2 | Any other 3 of 5 |
Insulin Resistance | IGT/IFG/IR | Plasma insulin < 75th percentile | - | - | - |
Blood Glucose | IFG/IGT/T2DM | IFG/IGT (excludes diabetes) |
≥ 110 mg/gL (includes diabetes) |
≥ 100 mg/gL | ≥ 100 mg/gL (includes diabetes) |
Dyslipidemia | TG ≥ 150 mg/dL HDL-C Men < 35mg/dL Women < 39mg/dL |
TG ≥ 150 mg/dL HDL-C < 39mg/dL |
TG ≥ 150 mg/dL HDL-C Men < 40 mg/dL Women < 50 mg/dL |
TG ≥ 150 mg/dL or on TG treatment HDL-C Men < 40 mg/dL Women < 50 mg/dL or HDL treatment |
TG ≥ 150 mg/dL or on TG treatment HDL-C Men < 40 mg/dL Women < 50 mg/dL or HDL treatment |
Blood Pressure | ≥ 140/90 mmHg | ≥ 140/90 mmHg or on treatment |
≥ 130/85 mmHg or on treatment |
≥ 130/85 mmHg or on treatment |
≥ 130/85 mmHg or on treatment |
Obesity | Waist:Hip (W:H) ratio Man > 0,9 Women > 0,85 and/or BMI > 30 Kg/m2 |
WC Men ≥ 94 cm Women ≥ 80 cm |
WC Men ≥ 102 cm Women ≥ 88 cm |
WC ≥ 94 cm | WC Men ≥ 102 cm Women ≥ 88 cm |
Other | Microalbuminuria | - | - | - | - |
ATP, Adult Treatment Panel; BMI, Body Mass Index; EGIR, European Group for Study of Insulin Resistance; HDL-C, High Density Lipoprotein Cholesterol; IDF, International Diabetes Federation; IFG, Impaired Fasting Glucose; IGT, Impaired Glucose Tolerance; IR, Insulin Resistance; TG, Triglycerides; T2DM, Type 2 Diabetes Mellitus; WC, Waist Circumference; WHO, World Health Organization; -: no reference values have been reported.